Laurel Damashek
Day 2: PARASOL APOL1 & MN Kickoff
The October 10 sessions of the PARASOL kickoff meeting for APOL1 kidney disease and ...
Day 1 Highlights: PARASOL APOL1 & MN Kickoff
The PARASOL APOL1 and MN kickoff meeting in Minneapolis on October 9, 2025 convened ...
PARASOL Project Expands Focus to APOL1, Membranous Nephropathy
The organizing committee of PARASOL (PROTEINURIA AND OTHER BIOMARKERS AS ENDPOINTS FOR ...
Inaugural Glomerular Disease Preceptorship Held at UKE Hamburg
The Hamburg Center for Kidney Health (HCKH) at Universitätsklinikum Hamburg-Eppendorf ...
NEJM "Science behind the Study" Editorial: Kidney Disease and Antinephrin Antibodies
Don't miss the new "Science behind the Study" editorial by Jochen Reiser, MD, PhD ...
Anti-nephrin autoantibodies in minimal change disease and idiopathic NS
New research demonstrates role of anti-nephrin autoantibodies as causative factor and ...
FSGS and NS Research Funding Opportunities Through PRMRP
The US Department of Defense includes FSGS and nephrotic syndrome as two of the priority ...
ISGD President Tobias B. Huber Awarded Prestigious ERC Advanced Grant to Study FSGS
Professor Dr. Tobias B. Huber, the inaugural President of the International Society of ...
New Era Act Introduced in Congress
We are thrilled to share that the New Era of Preventing End-Stage Kidney Disease Act ...
Announcing the PARASOL Project: PROTEINURIA AND GFR AS CLINICAL TRIAL ENDPOINTS IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS
ISGD is collaborating in a multidisciplinary effort to tackle the urgent problem of ...